+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Innovations in Pain Management: A Technology Blueprint to Counter Opiod Addiction

  • ID: 4591049
  • Report
  • June 2018
  • Region: Global
  • 47 Pages
  • Frost & Sullivan
1 of 2

Enquire about COVID-19 updates for this product.

Enquire Now
Exploring Viable Strategies to Reduce Drug-Device Competitive Initiatives that can Deliver the Right Value of Care for Clinically Safe & Effective Management of Pain Disorders

Over the past several decades drug therapies for clinically safe and effective management of various types of pain, classified as being acute, chronic, breakthrough, nerve, and bone-related have been treated with the use of opioids, NSAIDS, anticonvulsants, and antidepressants. However, increasing reliance on their use for prolonged intervals and side-effects associated with the same has led to an increasing demand for drug-alternatives that can improve or retain the quality of life of patients while managing their pain. Medtech developers have been addressing these concerns over the past two decades with the introduction of device-based pain management therapies.

This research service focuses on the need for replacing opioids and other drug-based therapies for pain control and underlying implications for various stakeholders involved in enabling the adoption of such therapies for clinically safe and effective management of pain disorders. The research service covers a snapshot of the current industry scenario, including coverage of market growth, top players, major drivers and challenges that are challenging the status quo of companies operating across developed and emerging economies. The chapters also cover game-changing technologies and research initiatives that drive business performance in competitive portfolios. The research evaluates industry collaborations that are bridging the device-drug gap in treating pain. A comprehensive analysis of value chain and stakeholder concerns along the value stream is evaluated in-depth through the voice of the stakeholder approach. The research service evaluates the value of care delivered by drug and device therapies prescribed today for managing pain.

Note: Product cover images may vary from those shown
2 of 2

1. Executive Summary
1.1 Research Scope
1.2 Research Methodology
1.3 Miniaturization, Cybersecurity, and Wearables are Technology Trends Driving Industry Growth
1.4 Resistance toward Intake of Opioids Drive Growth of Device-based Therapies
1.5 Progressive Shift toward Very High Margin Pain Management Therapies

2. Industry Snapshot & Analysis
2.1 50% of Device-based Pain Management Therapies Market Comprises of Neuromodulation Therapies
2.2 Patent Expiry of Blockbuster Drugs is Driving the Sales of Device-based Therapies
2.3 Device-based Therapies Work at an Organ Level, Enhancing Clinical Effectiveness
2.4 Strong Regulatory Push toward Use of Pain Control Devices against Use of Opioids
2.5 North America is Most Favourable for Wide-Scale Launch and Commercialization of Pain Management Devices

3. Competitor Landscape & Dynamics
3.1 Strong Competitive Push from Combination Products and Device Therapies against Drug Therapies for Pain Control
3.2 Combination Therapies are Replacing Drug Therapies for Managing various Pain Disorders
3.3 eCommerce Plays a Critical Role in Driving Adoption of Pain Management Devices
3.4 The US and Japan are Generating Innovative Intellectual Property Assets around Pain Management Therapies
3.5 Development of Hybrid Therapy Systems are Increasing the Pace of Mergers & Acquisitions within the Industry
3.6 Co-creation Plays a Critical Role in Developing Clinically Safe & Effective Pain Management Therapies

4. Customer Analysis
4.1 Four Major End-user Segments Define Majority of Market for Pain Management Therapies
4.2 A Critical Demand Exists for Reimbursement of Pain Management Therapies in Regions outside the United States

5. Industry Value Chain
5.1 Value Adding Stakeholders are Critical to Innovation for the Global Pain Management Industry
5.2 University Research Grants in Emerging Economies are Not Adequately Supported for Commercialization of New Therapies
5.3 CROs Play a Critical Role in Complying with Regulatory Requirements of New Markets
5.4 Hospitals Still Serve to be Major Brand Advocates for Pain Management Therapies
5.5 MedTech and Pharma Companies Need to Focus on Creating Innovation Networks

6. Delivering Clinical Value
6.1 Value of Care is a Ratio of Health Outcomes Delivered to the Ease of Access to the Therapy
6.2 Invasive Options - Electrical Stimulation & Intrathecal Pumps are Delivering High Value of Care to Patients

7. Recommendations and Analyst Viewpoint
7.1 Bundled Care and Low Claim Complexity are Critical to Adoption among Mass Market Segments
7.2 Setting the Right Design Elements Early During Product Development Enhances Speed of Commercialization
7.3 Good Market Potential for Development of Therapies that can Detect Pain and Also Deliver Appropriate Therapy

8. Patent Landscape Assessment
8.1 North America, Australia, and China Dominate the Global Patent Landscape with a High Intensity of Patents
8.2 Development of Implantable Neuromodulation System using Current Distribution Circuitry
8.3 New Intellectual Properties Developed Around Nasal Stimulation Methods
8.4 Development of Conductive Pad for Effective Pain Relieving
8.5 Key Contacts
8.6 Legal Disclaimer

Note: Product cover images may vary from those shown
3 of 2

Loading
LOADING...

Adroll
adroll